Biogen IncNASDAQ:BIIB
- LAST PRICE234.1300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots232.6500/ 1
- Ask / Lots235.0000/ 1
- Open / Previous Close0.0000 / 234.1300
- Day Range---
- 52 Week Range
- Volume3
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BIIB |
|---|---|---|
| 09:32 ET | 9126 | 229.725 |
| 09:34 ET | 400 | 230.485 |
| 09:36 ET | 200 | 229.85 |
| 09:38 ET | 700 | 230.97 |
| 09:39 ET | 100 | 230.565 |
| 09:41 ET | 930 | 231.24 |
| 09:43 ET | 1570 | 232 |
| 09:45 ET | 2500 | 232.38 |
| 09:48 ET | 2900 | 232.59 |
| 09:50 ET | 1119 | 232.63 |
| 09:52 ET | 2931 | 232.8 |
| 09:54 ET | 1301 | 232.4 |
| 09:56 ET | 2000 | 232.385 |
| 09:57 ET | 350 | 232.06 |
| 09:59 ET | 300 | 232.205 |
| 10:01 ET | 3118 | 232.73 |
| 10:03 ET | 2722 | 233.305 |
| 10:06 ET | 4500 | 233.14 |
| 10:08 ET | 1436 | 233.37 |
| 10:10 ET | 2307 | 233.38 |
| 10:12 ET | 1778 | 233.7 |
| 10:14 ET | 400 | 233.08 |
| 10:15 ET | 611 | 233.0825 |
| 10:17 ET | 200 | 233.48 |
| 10:19 ET | 432 | 233.31 |
| 10:21 ET | 300 | 233.12 |
| 10:24 ET | 100 | 233.015 |
| 10:26 ET | 800 | 232.815 |
| 10:28 ET | 200 | 232.53 |
| 10:30 ET | 1081 | 232.505 |
| 10:32 ET | 3284 | 233.13 |
| 10:33 ET | 2279 | 232.7 |
| 10:35 ET | 1455 | 232.59 |
| 10:37 ET | 1200 | 232.77 |
| 10:39 ET | 772 | 232.71 |
| 10:42 ET | 642 | 232.81 |
| 10:44 ET | 100 | 232.595 |
| 10:46 ET | 300 | 232.92 |
| 10:48 ET | 500 | 232.67 |
| 10:50 ET | 100 | 232.7 |
| 10:51 ET | 2046 | 232.32 |
| 10:53 ET | 400 | 232.14 |
| 10:55 ET | 200 | 231.73 |
| 10:57 ET | 1186 | 231.79 |
| 11:00 ET | 2023 | 231.63 |
| 11:02 ET | 1985 | 231.88 |
| 11:04 ET | 300 | 232.05 |
| 11:06 ET | 900 | 232.12 |
| 11:08 ET | 893 | 231.79 |
| 11:09 ET | 500 | 231.73 |
| 11:11 ET | 750 | 231.615 |
| 11:13 ET | 1300 | 231.78 |
| 11:15 ET | 800 | 232.02 |
| 11:18 ET | 200 | 232.175 |
| 11:20 ET | 200 | 232.26 |
| 11:22 ET | 200 | 232.45 |
| 11:24 ET | 5896 | 232.135 |
| 11:26 ET | 400 | 232.25 |
| 11:27 ET | 100 | 232.195 |
| 11:29 ET | 500 | 232.09 |
| 11:31 ET | 1592 | 231.83 |
| 11:33 ET | 953 | 231.705 |
| 11:36 ET | 806 | 231.2 |
| 11:38 ET | 506 | 231.38 |
| 11:40 ET | 721 | 231.18 |
| 11:42 ET | 700 | 231.21 |
| 11:44 ET | 2409 | 230.93 |
| 11:45 ET | 800 | 230.875 |
| 11:47 ET | 1897 | 231.1 |
| 11:49 ET | 500 | 231.04 |
| 11:51 ET | 800 | 231.13 |
| 11:54 ET | 1500 | 231.1663 |
| 11:56 ET | 700 | 231.44 |
| 11:58 ET | 400 | 231.405 |
| 12:00 ET | 600 | 231.61 |
| 12:02 ET | 200 | 231.58 |
| 12:03 ET | 591 | 231.505 |
| 12:05 ET | 315 | 231.25 |
| 12:07 ET | 700 | 231.2 |
| 12:09 ET | 210 | 231.36 |
| 12:12 ET | 600 | 230.81 |
| 12:14 ET | 106 | 231.0901 |
| 12:16 ET | 433 | 231.0999 |
| 12:18 ET | 749 | 231.17 |
| 12:20 ET | 777 | 231.28 |
| 12:21 ET | 342 | 231.25 |
| 12:23 ET | 700 | 231.32 |
| 12:25 ET | 771 | 231.1 |
| 12:27 ET | 1000 | 231.6 |
| 12:30 ET | 500 | 231.74 |
| 12:32 ET | 750 | 231.78 |
| 12:34 ET | 400 | 231.81 |
| 12:36 ET | 600 | 231.94 |
| 12:38 ET | 800 | 231.93 |
| 12:39 ET | 1400 | 231.97 |
| 12:41 ET | 600 | 231.97 |
| 12:43 ET | 1300 | 232.22 |
| 12:45 ET | 200 | 232.41 |
| 12:48 ET | 301 | 232.39 |
| 12:50 ET | 1600 | 232.39 |
| 12:52 ET | 1600 | 231.91 |
| 12:54 ET | 600 | 232.01 |
| 12:56 ET | 550 | 232.11 |
| 12:57 ET | 800 | 231.925 |
| 12:59 ET | 100 | 232.03 |
| 01:01 ET | 800 | 231.925 |
| 01:03 ET | 600 | 231.95 |
| 01:06 ET | 1268 | 232.035 |
| 01:08 ET | 400 | 232.075 |
| 01:10 ET | 100 | 232.24 |
| 01:12 ET | 1200 | 232.15 |
| 01:14 ET | 300 | 232.09 |
| 01:15 ET | 1100 | 232.23 |
| 01:17 ET | 300 | 232.44 |
| 01:19 ET | 600 | 232.32 |
| 01:21 ET | 500 | 232.46 |
| 01:24 ET | 1068 | 232.29 |
| 01:26 ET | 300 | 232.31 |
| 01:28 ET | 900 | 232.315 |
| 01:30 ET | 900 | 232.565 |
| 01:32 ET | 1501 | 232.285 |
| 01:33 ET | 2525 | 232.04 |
| 01:35 ET | 1666 | 232.32 |
| 01:37 ET | 1274 | 232.29 |
| 01:42 ET | 200 | 232.265 |
| 01:44 ET | 800 | 232.21 |
| 01:46 ET | 200 | 232.14 |
| 01:48 ET | 2945 | 232.358 |
| 01:50 ET | 100 | 232.325 |
| 01:51 ET | 1710 | 232.335 |
| 01:53 ET | 1300 | 232.38 |
| 01:55 ET | 800 | 232.33 |
| 01:57 ET | 1800 | 232.43 |
| 02:00 ET | 300 | 232.355 |
| 02:02 ET | 1046 | 232.205 |
| 02:04 ET | 1476 | 232.23 |
| 02:06 ET | 1430 | 232.225 |
| 02:08 ET | 500 | 232.4 |
| 02:09 ET | 1250 | 232.46 |
| 02:11 ET | 300 | 232.32 |
| 02:13 ET | 900 | 232.34 |
| 02:15 ET | 1215 | 232.4 |
| 02:18 ET | 1402 | 232.555 |
| 02:20 ET | 700 | 232.52 |
| 02:22 ET | 1200 | 232.6001 |
| 02:24 ET | 815 | 232.95 |
| 02:26 ET | 1960 | 232.91 |
| 02:27 ET | 700 | 233.08 |
| 02:29 ET | 1080 | 233.18 |
| 02:31 ET | 2416 | 233.005 |
| 02:33 ET | 200 | 233.16 |
| 02:36 ET | 2450 | 233.115 |
| 02:38 ET | 900 | 233.32 |
| 02:40 ET | 2200 | 233.21 |
| 02:42 ET | 1232 | 233.22 |
| 02:44 ET | 1800 | 233.385 |
| 02:45 ET | 900 | 233.45 |
| 02:47 ET | 500 | 233.61 |
| 02:49 ET | 2038 | 233.275 |
| 02:51 ET | 1416 | 233.27 |
| 02:54 ET | 1822 | 233.34 |
| 02:56 ET | 1111 | 233.31 |
| 02:58 ET | 2093 | 233.02 |
| 03:00 ET | 1174 | 232.905 |
| 03:02 ET | 2482 | 232.55 |
| 03:03 ET | 1299 | 232.175 |
| 03:05 ET | 2301 | 232.22 |
| 03:07 ET | 500 | 232.28 |
| 03:09 ET | 1700 | 232.42 |
| 03:12 ET | 964 | 232.35 |
| 03:14 ET | 900 | 232.36 |
| 03:16 ET | 1300 | 232.45 |
| 03:18 ET | 1302 | 232.845 |
| 03:20 ET | 1527 | 232.86 |
| 03:21 ET | 1050 | 232.99 |
| 03:23 ET | 4802 | 233.65 |
| 03:25 ET | 3757 | 233.79 |
| 03:27 ET | 3508 | 233.615 |
| 03:30 ET | 1200 | 233.82 |
| 03:32 ET | 4446 | 233.8 |
| 03:34 ET | 4671 | 233.745 |
| 03:36 ET | 5600 | 233.775 |
| 03:38 ET | 5590 | 233.95 |
| 03:39 ET | 6398 | 233.83 |
| 03:41 ET | 6843 | 233.645 |
| 03:43 ET | 5495 | 233.8 |
| 03:45 ET | 5900 | 233.92 |
| 03:48 ET | 7141 | 233.97 |
| 03:50 ET | 7952 | 234.225 |
| 03:52 ET | 9927 | 234.33 |
| 03:54 ET | 10916 | 234.125 |
| 03:56 ET | 17344 | 233.85 |
| 03:57 ET | 14644 | 233.91 |
| 03:59 ET | 33686 | 234.13 |
Today
Contact Levi & Korsinsky by July 22, 2024 Deadline to Join Class Action Against Biogen Inc. (BIIB), from 17 minutes ago by Dow Jones
17 minutes ago by Dow JonesBIIB SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors Can Join the Class Action Lawsuit!, from 35 minutes ago by Dow Jones
35 minutes ago by Dow Jones
Yesterday
BIOGEN INVESTOR NOTICE: Biogen Inc. (BIIB) Shareholders are Reminded of July 2024 Deadline in Securities Action and Are Encouraged to Contact BFA Law, from 14 hours ago by Dow Jones
14 hours ago by Dow JonesInvestors in Biogen Inc. Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB, from 15 hours ago by Dow Jones
15 hours ago by Dow JonesBIIB Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Biogen Inc. - Contact Kessler Topaz Meltzer & Check, LLP, from 15 hours ago by Dow Jones
15 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biogen Inc | 32.8B | 29.3x | -18.14% |
ICON PLC | 26.9B | 38.6x | +4.68% |
Grifols SA | 6.2B | 75.4x | --- |
IQVIA Holdings Inc | 39.9B | 29.6x | +46.62% |
Biontech SE | 23.9B | 192.9x | --- |
Moderna Inc | 54.6B | -9.3x | --- |
Company Information
Biogen Inc. is a global biopharmaceutical company focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. The Company’s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS; and FUMADERM for the treatment of severe plaque psoriasis. It also has collaborations for the commercialization of LEQEMBI, ZURZUVAE, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS, LUNSUMIO, and COLUMVI. It commercializes a portfolio of biosimilars of advanced biologics including BENEPALI, IMRALDI, FLIXABI, and BYOOVIZ.
Contact Information
- Headquarters
- 225 Binney StreetCAMBRIDGE, MA, United States 02142
- Phone
- 781-464-2000
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Caroline Dorsa
- President, Chief Executive Officer, Director
- Christopher Viehbacher
- Chief Financial Officer, Executive Vice President
- Michael McDonnell
- Chief Human Resource Officer, Executive Vice President
- Ginger Gregory
- Executive Vice President, Chief Legal Officer, Secretary
- Susan Alexander
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $32.8B |
|---|---|
Revenue (TTM) | $9.7B |
Shares Outstanding | 145.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.02 |
EPS | $8.00 |
Book Value | $102.14 |
P/E Ratio | 29.3x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | 19.3x |
Operating Margin | 17.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
